Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1984-12-17
1987-03-31
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 3, A61K 3700
Patent
active
046543244
ABSTRACT:
A pharmaceutical composition which comprises human proinsulin in association with a pharmaceutically acceptable carrier is useful in controlling a diabetic condition and in promoting attainment of natural hormonal homeostasis, thereby preventing or substantially diminishing or retarding diabetic complications.
REFERENCES:
patent: 3868358 (1975-02-01), Jackson
Steiner et al--Diabetes, vol. 17, No. 12, Dec. 1968, pp. 725-736.
Oyer et al., J. Biol. Chem., 246, 1375-1386 (1971).
Yu et al., J. Biol. Chem., 248, 3753-3761 (1973).
Horwitz et al., J. Clin. Invest., 55, 1278-1283 (1975).
Kitabchi, Metabolism, 26, 547-587 (1977).
Yanaihara et al., Diabetes, 27 (Suppl. 1), 149-160 (1978).
Yanaihara et al., Characterization of Synthetic Human Proinsulin and C-Peptide, Proinsulin, Insulin, C-Peptide, 41-49 (Excerpta Medica, 1979).
Rees et al., Diabetes, 18, 341 (1969).
Galloway et al., Diabetes, 18, 341 (1969).
Galloway et al., J. Lab. Clin. Med., 78, 991-992 (1971).
Kitabchi, South. Med. J., 65, 833-838 (1972).
Low et al., Nature, 248, 339-340 (1974).
Starr et al., J. Clin. Endocrinol. Metab., 38, 305-308 (1974).
Tompkins et al., Diabetologia, 20, 94-101 (1981).
Fineberg et al., Diabetes, 22, 676-686 (1973).
Chance Ronald E.
Frank Bruce H.
Galloway John A.
Eli Lilly and Company
Martens, Jr. William C.
Waddell Frederick E.
LandOfFree
Human proinsulin pharmaceutical formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human proinsulin pharmaceutical formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human proinsulin pharmaceutical formulations will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2212961